Mix and match: Building manifold binding sites

Nature Biotechnology

Volumn 15, Issue 2, 1997, Pages 125-126

  Hoogenboom, Hennie R ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; NEW DRUG;

DRUG BINDING SITE; DRUG DESIGN; DRUG RESEARCH; DRUG STRUCTURE; GENETIC ENGINEERING; IMMUNOTHERAPY; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ANTIBODIES, BISPECIFIC; CLONING, MOLECULAR; DEXTRANS; DIMERIZATION; DRUG DESIGN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031043433     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0297-125     Document Type: Article

References (11)

1. Holliger, P. and Winter, G. 1993. Curr. Opin. Biotechnol. 4:446–449.
2. Colonna, M.J. and Morrison, S.L. 1997. Nature Biotechnology 15:159–163.
3. Holliger, P., Prospero, T. and Winter, G. 1993. Proc. Natl Acad. Sci. USA. 90:6444–6448.
4. Kortt, A.A. et al. 1997. Protein Eng., in press.
5. McGuinness, B.T. et al. 1996. Nature Biotechnology 14:1149–1153.
6. Pack, P. et al. 1995. J. Mol. Biol. 246:28–34.
7. Neri, D. et al. 1995. J. Mol. Biol. 246:367–373.
8. Keck, P.C. and Huston, J.S. 1996. Biophys. J. 71:2002–2011.
9. Renner, C. et al. 1994. Science 264:833–835.
10. Nitta T. et al. 1990. Lancet 335:368–371.
11. Featherstone, C. 1996. Lancet 348:536.